Monsanto Company (MON) Stake Decreased by Dowling & Yahnke LLC
Dowling & Yahnke LLC decreased its stake in Monsanto Company (NYSE:MON) by 1.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,360 shares of the basic materials company’s stock after selling 64 shares during the period. Dowling & Yahnke LLC’s holdings in Monsanto were worth $516,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Fisher Asset Management LLC purchased a new position in Monsanto during the first quarter valued at $213,000. Delta Asset Management LLC TN raised its position in Monsanto by 0.5% in the first quarter. Delta Asset Management LLC TN now owns 1,950 shares of the basic materials company’s stock valued at $221,000 after buying an additional 10 shares in the last quarter. Duncker Streett & Co. Inc. raised its position in Monsanto by 5.3% in the first quarter. Duncker Streett & Co. Inc. now owns 18,809 shares of the basic materials company’s stock valued at $2,129,000 after buying an additional 948 shares in the last quarter. Livingston Group Asset Management CO operating as Southport Capital Management raised its position in Monsanto by 8.2% in the first quarter. Livingston Group Asset Management CO operating as Southport Capital Management now owns 4,004 shares of the basic materials company’s stock valued at $453,000 after buying an additional 302 shares in the last quarter. Finally, Crossvault Capital Management LLC raised its position in Monsanto by 28.2% in the first quarter. Crossvault Capital Management LLC now owns 4,200 shares of the basic materials company’s stock valued at $475,000 after buying an additional 925 shares in the last quarter. Institutional investors own 74.79% of the company’s stock.
Shares of Monsanto Company (NYSE MON) opened at 116.88 on Thursday. Monsanto Company has a one year low of $97.35 and a one year high of $118.97. The stock’s 50 day moving average is $117.23 and its 200-day moving average is $115.65. The company has a market cap of $51.35 billion, a P/E ratio of 25.24 and a beta of 1.07.
Monsanto (NYSE:MON) last posted its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. The firm had revenue of $4.23 billion during the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.17 EPS. Equities research analysts forecast that Monsanto Company will post $4.89 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be given a dividend of $0.54 per share. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.85%. Monsanto’s dividend payout ratio is currently 46.75%.
Several research analysts have recently weighed in on MON shares. Zacks Investment Research upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price objective on the stock in a research note on Friday, June 16th. UBS AG lowered shares of Monsanto from a “positive” rating to a “neutral” rating in a research note on Tuesday, June 27th. Susquehanna Bancshares Inc reiterated a “neutral” rating and issued a $128.00 price target (up previously from $125.00) on shares of Monsanto in a research note on Tuesday, June 27th. Vetr upgraded shares of Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target on the stock in a research note on Tuesday, June 27th. Finally, Royal Bank Of Canada reiterated a “sector perform” rating and issued a $128.00 price target (up previously from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $123.43.
In other news, EVP Steven Mizell sold 11,300 shares of the stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the transaction, the executive vice president now directly owns 55,011 shares in the company, valued at approximately $6,522,654.27. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The disclosure for this sale can be found here. Insiders have sold a total of 74,470 shares of company stock valued at $8,791,281 over the last quarter. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with Analyst Ratings Network's FREE daily email newsletter.